Asensus Surgical/ASXC

$0.25

-0.32%
-
1D1W1MYTD1YMAX

About Asensus Surgical

Asensus Surgical, Inc. is a medical device company digitizing the interface between the surgeon and patient to reimagine surgery through Performance-Guided Surgery to enable surgeons to deliver outcomes to patients and establish a new standard of surgery. It operates in one business segment, which is the research, development and sale of medical device robotics to improve minimally invasive surgery. It is developing the LUNA Surgical System, a robotic and instrument system as a foundation of its Digital Surgery solution. These systems shall be powered by the Intelligent Surgical Unit to enhance surgeon control and reduce surgical variability. With the addition of machine vision, Augmented Intelligence, and deep learning capabilities throughout the surgical experience, it intends to holistically address the clinical, cognitive and economic shortcomings that drive surgical outcomes and value-based healthcare. It is also working to incorporate all of this in the LUNA Surgical System.

Ticker

ASXC

Sector

Healthcare

Trading on

AMEX

Industry

Medical Equipment & Supplies

CEO

Anthony Fernando

Employees

207

Headquarters

Durham, United States

Asensus Surgical Metrics

BasicAdvanced
$68M
Market cap
-
P/E ratio
-$0.32
EPS
1.41
Beta
-
Dividend rate
$68M
1.40626
$0.76
$0.20
1.59M
2.881
2.313
-89.57%
-117.89%
-103.14%
7.928
1.982
2.113
21.02%
1.05%
39.27%

What the Analysts think about Asensus Surgical

Analyst Ratings

Majority rating from 2 analysts.
Hold

Price Targets

Average projection from 1 analyst.
40% upside
High $0.35
Low $0.35
$0.25
Current price
$0.35
Average price target

Asensus Surgical Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-318.51% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$5.4M
440%
Net income
$-17.2M
-6.01%
Profit margin
-318.51%
-82.6%

Asensus Surgical Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 25%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
-$0.09
-$0.09
-$0.07
-$0.06
-
Expected
-$0.08
-$0.08
-$0.07
-$0.08
-$0.05
Surprise
12.5%
12.5%
0%
-25%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Asensus Surgical stock?

Asensus Surgical (ASXC) has a market cap of $68M as of April 23, 2024.

What is the P/E ratio for Asensus Surgical stock?

The price to earnings (P/E) ratio for Asensus Surgical (ASXC) stock is 0 as of April 23, 2024.

Does Asensus Surgical stock pay dividends?

No, Asensus Surgical (ASXC) stock does not pay dividends to its shareholders as of April 23, 2024.

When is the next Asensus Surgical dividend payment date?

Asensus Surgical (ASXC) stock does not pay dividends to its shareholders.

What is the beta indicator for Asensus Surgical?

Asensus Surgical (ASXC) has a beta rating of 1.41. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

What is the Asensus Surgical stock price target?

The target price for Asensus Surgical (ASXC) stock is $0.35, which is 40% above the current price of $0.25. This is an average based on projections from 1 analyst, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Asensus Surgical stock

Buy or sell Asensus Surgical stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing